Vaccine. 2007 Apr 20;25(16):3080-4. Epub 2007 Jan 22.

Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease.

Nøkleby H, Aavitsland P, O'Hallahan J, Feiring B, Tilman S, Oster P.

Source

Norwegian Institute of Public Health (NIPH), P.O. Box 4404, Nydalen, N-0403 Oslo, Norway. hanne.nokleby@fhi.no

Abstract

MenBvac is an OMV vaccine against systemic serogroup B Neisseria meningitidis disease. MenBvac was developed for control of a B:15:P1.7,16 subtype epidemic in Norway and administered to 180,000 subjects in 28 clinical studies. MeNZB, a daughter vaccine of MenBvac, was developed for a clonal B:4:P1.7b,4 epidemic in New Zealand and administered to 1 million people <20 years. The vaccines were similar regarding reactogenicity profile. Serious adverse events (SAEs) in general and particularly neurologic SAEs were very rare. Despite frequently reported local reactions and fever in those under 5 years, these OMV-based vaccines containing 25 microg antigen can be considered safe for use in all age groups.

Comment in

Vaccine. 2007 Sep 28;25(39-40):6833; author reply 6833-4.

PMID:: 17287053; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Meningococcal Infections - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Immunogenicity and safety of a combination of two serogroup B meningococcal outer membrane vesicle vaccines. [Clin Vaccine Immunol. 2007]
Immunogenicity and safety of a combination of two serogroup B meningococcal outer membrane vesicle vaccines.
Sandbu S, Feiring B, Oster P, Helland OS, Bakke HS, Naess LM, Aase A, Aaberge IS, Kristoffersen AC, Rydland KM, et al. Clin Vaccine Immunol. 2007 Sep; 14(9):1062-9. Epub 2007 Jul 18.
New zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months. [Pediatr Infect Dis J. 2007]
New zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months.
Wong S, Lennon D, Jackson C, Stewart J, Reid S, Crengle S, Tilman S, Aaberge I, O'Hallahan J, Oster P, et al. Pediatr Infect Dis J. 2007 Apr; 26(4):345-50.
Immunogenicity, reactogenicity, and safety of a P1.7b,4 strain-specific serogroup B meningococcal vaccine given to preteens. [Clin Vaccine Immunol. 2007]
Immunogenicity, reactogenicity, and safety of a P1.7b,4 strain-specific serogroup B meningococcal vaccine given to preteens.
Hosking J, Rasanathan K, Mow FC, Jackson C, Martin D, O'Hallahan J, Oster P, Ypma E, Reid S, Aaberge I, et al. Clin Vaccine Immunol. 2007 Nov; 14(11):1393-9. Epub 2007 Sep 26.
Review Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. [Vaccine. 2009]
Review Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.
Holst J, Martin D, Arnold R, Huergo CC, Oster P, O'Hallahan J, Rosenqvist E. Vaccine. 2009 Jun 24; 27 Suppl 2:B3-12. Epub 2009 May 28.
Review Recent developments in vaccines to prevent meningococcal serogroup B infections. [Curr Opin Mol Ther. 2003]
Review Recent developments in vaccines to prevent meningococcal serogroup B infections.
Vermont CL, van den Dobbelsteen GP, de Groot R. Curr Opin Mol Ther. 2003 Feb; 5(1):33-8.

See reviews... See all...

Cited by 7 PubMed Central articles

A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines. [Clin Vaccine Immunol. 2011]
A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines.
Koeberling O, Delany I, Granoff DM. Clin Vaccine Immunol. 2011 May; 18(5):736-42. Epub 2011 Mar 2.
Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningococcal isolates. [Clin Vaccine Immunol. 2011]
Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningococcal isolates.
Kimura A, Toneatto D, Kleinschmidt A, Wang H, Dull P. Clin Vaccine Immunol. 2011 Mar; 18(3):483-6. Epub 2010 Dec 22.
Review Review of meningococcal group B vaccines. [Clin Infect Dis. 2010]
Review Review of meningococcal group B vaccines.
Granoff DM. Clin Infect Dis. 2010 Mar 1; 50 Suppl 2:S54-65.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisse...
Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease.
Vaccine. 2007 Apr 20 ;25(16):3080-4. Epub 2007 Jan 22 .

PubMed
Protein biogenesis in Archaea: addressing translation initiation using an in vit...
Protein biogenesis in Archaea: addressing translation initiation using an in vitro protein synthesis system for Haloferax volcanii.
FEMS Microbiol Lett. 2007 May ;270(1):34-41. Epub 2007 Feb 5 .

PubMed
CYP2C8 and antimalaria drug efficacy.
CYP2C8 and antimalaria drug efficacy.
Pharmacogenomics. 2007 Feb ;8(2):187-98.

PubMed
Sample medication dispensing in a residency practice.
Sample medication dispensing in a residency practice.
J Fam Pract. 1992 Jan ;34(1):42-8.

PubMed
RB1 germ-line deletions in Argentine retinoblastoma patients.
RB1 germ-line deletions in Argentine retinoblastoma patients.
Mol Diagn Ther. 2007 ;11(1):55-61.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease.

Source

Abstract

Comment in

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 7 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information